Amanda Winters

3.5k total citations · 1 hit paper
39 papers, 1.6k citations indexed

About

Amanda Winters is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Amanda Winters has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 16 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Amanda Winters's work include Acute Myeloid Leukemia Research (20 papers), Histone Deacetylase Inhibitors Research (7 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Amanda Winters is often cited by papers focused on Acute Myeloid Leukemia Research (20 papers), Histone Deacetylase Inhibitors Research (7 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Amanda Winters collaborates with scholars based in United States, Sweden and Canada. Amanda Winters's co-authors include Kathrin M. Bernt, Craig T. Jordan, Daniel A. Pollyea, Brett M. Stevens, Clayton A. Smith, Diana Abbott, Jonathan A. Gutman, Courtney L. Jones, Angelo D’Alessandro and Shanshan Pei and has published in prestigious journals such as Nature Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Amanda Winters

34 papers receiving 1.6k citations

Hit Papers

Venetoclax with azacitidine disrupts energy metabolism an... 2018 2026 2020 2023 2018 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia
    2018 481 citations Daniel A. Pollyea, Brett M. Stevens et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amanda Winters United States 15 1.1k 999 268 262 250 39 1.6k
Bertil Uggla Sweden 14 600 0.6× 485 0.5× 123 0.5× 162 0.6× 414 1.7× 31 1.1k
Carolyn Grove Australia 14 772 0.7× 721 0.7× 211 0.8× 84 0.3× 128 0.5× 29 1.3k
Eli Estey United States 8 782 0.7× 480 0.5× 85 0.3× 161 0.6× 136 0.5× 10 996
Carla Mazzone Italy 15 576 0.5× 479 0.5× 73 0.3× 191 0.7× 183 0.7× 47 951
Ulrike Schäkel Germany 12 1.7k 1.6× 852 0.9× 157 0.6× 450 1.7× 364 1.5× 15 2.0k
Tanja A. Grüber United States 18 552 0.5× 306 0.3× 86 0.3× 555 2.1× 260 1.0× 51 1.1k
Simon Bomken United Kingdom 13 234 0.2× 376 0.4× 223 0.8× 202 0.8× 366 1.5× 32 964
Anuj Mahindra United States 17 918 0.9× 703 0.7× 67 0.3× 57 0.2× 477 1.9× 56 1.2k
Lia Perez United States 22 940 0.9× 322 0.3× 44 0.2× 223 0.9× 441 1.8× 80 1.3k
F. Dreyfus France 15 645 0.6× 462 0.5× 56 0.2× 106 0.4× 441 1.8× 56 1.2k

Countries citing papers authored by Amanda Winters

Since Specialization
Citations

This map shows the geographic impact of Amanda Winters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Winters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Winters more than expected).

Fields of papers citing papers by Amanda Winters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Winters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Winters. The network helps show where Amanda Winters may publish in the future.

Co-authorship network of co-authors of Amanda Winters

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Winters. A scholar is included among the top collaborators of Amanda Winters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Winters. Amanda Winters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kohler, M. Eric, Kimberly R. Jordan, Angela M. Ohm, et al.. (2025). Characterization of a multiplex digital PCR assay to quantify total T cells relative to chimeric antigen receptor-positive T cells. PubMed. 33(2). 200981–200981.
2.
Winters, Amanda, Mohd Minhajuddin, Brett M. Stevens, et al.. (2023). Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine. Haematologica. 109(6). 1766–1778. 5 indexed citations
3.
4.
Winters, Amanda, et al.. (2023). Emerging and Future Targeted Therapies for Pediatric Acute Myeloid Leukemia: Targeting the Leukemia Stem Cells. Biomedicines. 11(12). 3248–3248. 2 indexed citations
5.
Winters, Amanda, Diana Abbott, Mohd Minhajuddin, et al.. (2022). Outcomes Are Similar After Allogeneic Hematopoietic Stem Cell Transplant for Newly Diagnosed Acute Myeloid Leukemia Patients who Received Venetoclax + Azacitidine Versus Intensive Chemotherapy. Transplantation and Cellular Therapy. 28(10). 694.e1–694.e9. 32 indexed citations
6.
7.
Siegele, Bradford, Anat Stemmer‐Rachamimov, Henrik Lilljebjörn, et al.. (2022). N‐terminus DUX4‐immunohistochemistry is a reliable methodology for the diagnosis of DUX4‐fused B‐lymphoblastic leukemia/lymphoma (N‐terminus DUX4 IHC for DUX4‐fused B‐ALL). Genes Chromosomes and Cancer. 61(8). 449–458. 8 indexed citations
8.
Pollyea, Daniel A., Amanda Winters, Christine M. McMahon, et al.. (2021). Venetoclax and azacitidine followed by allogeneic transplant results in excellent outcomes and may improve outcomes versus maintenance therapy among newly diagnosed AML patients older than 60. Bone Marrow Transplantation. 57(2). 160–166. 56 indexed citations
9.
Stevens, Brett M., Courtney L. Jones, Daniel A. Pollyea, et al.. (2020). Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells. Nature Cancer. 1(12). 1176–1187. 178 indexed citations
10.
Stevens, Brett M., Amanda Winters, Jonathan A. Gutman, et al.. (2019). Sequential azacitidine and lenalidomide for patients with relapsed and refractory acute myeloid leukemia: Clinical results and predictive modeling using computational analysis. Leukemia Research. 81. 43–49. 4 indexed citations
11.
Stevens, Brett M., Wei Zhang, Daniel A. Pollyea, et al.. (2019). CD123 CAR T cells for the treatment of myelodysplastic syndrome. Experimental Hematology. 74. 52–63.e3. 35 indexed citations
12.
Stevens, Brett M., Courtney L. Jones, Amanda Winters, et al.. (2018). PTPN11 Mutations Confer Unique Metabolic Properties and Increase Resistance to Venetoclax and Azacitidine in Acute Myelogenous Leukemia. Blood. 132(Supplement 1). 909–909. 20 indexed citations
13.
Pollyea, Daniel A., Brett M. Stevens, Courtney L. Jones, et al.. (2018). Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia. Nature Medicine. 24(12). 1859–1866. 481 indexed citations breakdown →
14.
Stevens, Brett M., Nabilah Khan, Angelo D’Alessandro, et al.. (2018). Characterization and targeting of malignant stem cells in patients with advanced myelodysplastic syndromes. Nature Communications. 9(1). 3694–3694. 53 indexed citations
15.
Ye, Haobin, Biniam Adane, Nabilah Khan, et al.. (2018). Subversion of Systemic Glucose Metabolism as a Mechanism to Support the Growth of Leukemia Cells. Cancer Cell. 34(4). 659–673.e6. 80 indexed citations
16.
Winters, Amanda, et al.. (2017). Vitamin K Deficiency Presenting in an Infant with an Anterior Mediastinal Mass: A Case Report and Review of the Literature. SHILAP Revista de lepidopterología. 2017(1). 7628946–7628946.
17.
18.
Winters, Amanda & Kathrin M. Bernt. (2017). MLL-Rearranged Leukemias—An Update on Science and Clinical Approaches. Frontiers in Pediatrics. 5. 4–4. 277 indexed citations
19.
20.
Palermo, Christine, et al.. (2007). The AF4-mimetic peptide, PFWT, induces necrotic cell death in MV4-11 leukemia cells. Leukemia Research. 32(4). 633–642. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bertil Uggla Breakdown of academic impact, for papers by Carolyn Grove Breakdown of academic impact, for papers by Eli Estey Breakdown of academic impact, for papers by Carla Mazzone Breakdown of academic impact, for papers by Ulrike Schäkel Breakdown of academic impact, for papers by Tanja A. Grüber Breakdown of academic impact, for papers by Simon Bomken Breakdown of academic impact, for papers by Anuj Mahindra Breakdown of academic impact, for papers by Lia Perez Breakdown of academic impact, for papers by F. Dreyfus
Rankless by CCL
2026